Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Dissemination bottleneck in a murine model of inhalational anthrax.

Plaut RD, Kelly VK, Lee GM, Stibitz S, Merkel TJ.

Infect Immun. 2012 Sep;80(9):3189-93. doi: 10.1128/IAI.00515-12. Epub 2012 Jul 2.

2.

Nonhuman primate model of pertussis.

Warfel JM, Beren J, Kelly VK, Lee G, Merkel TJ.

Infect Immun. 2012 Apr;80(4):1530-6. doi: 10.1128/IAI.06310-11. Epub 2012 Jan 17.

3.

Development of a highly efficacious vaccinia-based dual vaccine against smallpox and anthrax, two important bioterror entities.

Merkel TJ, Perera PY, Kelly VK, Verma A, Llewellyn ZN, Waldmann TA, Mosca JD, Perera LP.

Proc Natl Acad Sci U S A. 2010 Oct 19;107(42):18091-6. doi: 10.1073/pnas.1013083107. Epub 2010 Oct 4.

4.

Role of anthrax toxins in dissemination, disease progression, and induction of protective adaptive immunity in the mouse aerosol challenge model.

Loving CL, Khurana T, Osorio M, Lee GM, Kelly VK, Stibitz S, Merkel TJ.

Infect Immun. 2009 Jan;77(1):255-65. doi: 10.1128/IAI.00633-08. Epub 2008 Oct 27.

5.

Anamnestic protective immunity to Bacillus anthracis is antibody mediated but independent of complement and Fc receptors.

Harvill ET, Osorio M, Loving CL, Lee GM, Kelly VK, Merkel TJ.

Infect Immun. 2008 May;76(5):2177-82. doi: 10.1128/IAI.00647-07. Epub 2008 Mar 3.

6.

Banks as a source of capital.

Kelly VK.

Top Health Care Financ. 1993 Summer;19(4):21-34. No abstract available.

PMID:
8337689

Supplemental Content

Loading ...
Support Center